시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 정맥 내(IV) 수액 요법 시장 보고서(2025년)
Intravenous (IV) Hydration Therapy Global Market Report 2025
상품코드 : 1824398
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

정맥 내(IV) 수액 요법 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 9.6%를 나타내 43억 9,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 소비자 중심의 개인화, 기업의 웰니스 프로그램에의 통합, 예방적 건강 대책, 피트니스·웰니스 투어리즘의 성장, 고령화 사회 수요에 기인하는 것으로 예측됩니다. 예측 기간의 주요 동향으로는 윤리적이고 지속 가능한 조달, 홀리스틱 건강 보양, 수분 공급 바 및 라운지, 정신 건강에 대한 관심 등이 있습니다.

향후 5년간의 성장률 9.6%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 아일랜드와 멕시코에서 수입되는 프리믹스 전해질 용액과 정맥 내 투여 세트의 비용을 증가시키고, 탈수 처리에 대한 접근을 저하시키고, 외래 치료비를 상승시킬 수 있기 때문에 미국의 클리닉을 혼란시킬 수 있습니다. 또한, 상호관세와 무역마찰의 격화와 제한에 의한 세계경제와 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.

만성질환의 유병률 급증이 예상되므로 정맥 내(IV) 수액 요법 시장의 대폭적인 성장이 전망됩니다. 이 치료법은 비타민과 필수 영양소의 정맥 내 투여를 포함하며 만성 질환과 싸우는 사람들에게 상당한 에너지 보충을 제공합니다. 2022년 9월 기준 세계보건기구(WHO)는 연간 사망자 수 4,100만 명이라는 놀라운 수치를 보고했으며, 세계의 비감염성 질환(NCDs) 또는 만성 질환으로 인한 사망자 수의 74%를 차지했습니다. 특히 심혈관질환이 1,790만명, 암이 930만명, 만성호흡기질환이 410만명, 당뇨병이 200만명의 사망에 기여하고 있습니다. 이러한 만성 질환 증가는 정맥 내(IV) 수액 요법 시장 성장을 가속하는 매우 중요한 요소입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Intravenous (IV) hydration therapy is a simple medical procedure involving the insertion of a small IV into the arm to deliver fluids directly into the bloodstream. This method facilitates faster absorption of nutrients, fluids, medications, and blood, aiding in the body's treatment and recovery process by utilizing the circulatory system.

The primary service categories within intravenous (IV) hydration therapy encompass immune boosters, energy boosters, skin care treatments, migraine relief, and other specialized therapies. Immunity boosters are products designed to enhance the immune system and reduce susceptibility to illnesses. These products come in medicated and non-medicated forms and cater to diverse end-users, including hospitals and clinics, wellness centers and spas, home healthcare services, and other relevant facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The intravenous(IV) hydration therapy market research report is one of a series of new reports from The Business Research Company that provides intravenous(IV) hydration therapy market statistics, including intravenous(IV) hydration therapy industry global market size, regional shares, competitors with an intravenous(IV) hydration therapy market share, detailed intravenous(IV) hydration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous(IV) hydration therapy industry. This intravenous (IV) hydration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous (iv) hydration therapy market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to medical treatments and procedures, athletic and sports performance, clinical management of dehydration, recovery from illnesses, and mobile and concierge services.

The intravenous (iv) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to consumer-centric personalization, integration into corporate wellness programs, preventive health measures, growth in fitness and wellness tourism, and aging population demands. Major trends in the forecast period include ethical and sustainable sourcing, holistic health retreats, hydration bars and lounges, and a focus on mental wellness.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. clinics by increasing costs for pre-mixed electrolyte solutions and IV administration sets imported from Ireland and Mexico, potentially reducing access to dehydration treatments and raising outpatient care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in the prevalence of chronic diseases is poised to drive significant growth in the intravenous (IV) hydration therapy market. This therapeutic approach involves the administration of vitamins and essential nutrients intravenously, offering a substantial energy boost to individuals grappling with chronic diseases. As of September 2022, the World Health Organization reported a staggering 41 million annual deaths, accounting for 74% of fatalities attributed to non-communicable diseases (NCDs) or chronic ailments globally. Notably, cardiovascular diseases contributed to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. This escalation in chronic disease prevalence is a pivotal factor propelling the growth of the intravenous (IV) hydration therapy market.

The continual rise in the aging population is poised to further fuel the expansion of the intravenous (IV) hydration therapy market. Characterized by an increasing proportion of elderly individuals in society, the aging population is effectively addressed by IV hydration therapy to combat dehydration and provide essential nutrients, thereby enhancing overall health and well-being. Projections from the World Health Organization in October 2022 indicated that, by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion during this period. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the increasing aging population stands as a significant driver for the intravenous (IV) hydration therapy market.

The intravenous (IV) hydration therapy market is experiencing a notable trend towards product innovation, with major companies leveraging new technologies to maintain their market positions. An illustrative example occurred in September 2022 when Concierge Medical Consultants Inc, a Canada-based group of board-certified physicians specializing in private, discreet, and personalized healthcare, introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver. This addition included a novel IV hydration service featuring six variations of Vitamindrip products such as hydration, recovery, energy, cosmetics, diet and detox, and immune boost. The scientifically formulated Vitamin drip, administered intravenously, effectively addresses dehydration and various disorders such as migraines, acute muscle spasms, asthma, upper respiratory tract infections, chronic sinusitis, and seasonal allergic rhinitis.

Major players in the intravenous (IV) hydration therapy market are directing their efforts towards the development of sterile solutions, particularly CBD isolate, to meet the growing demand for CBD infusion and gain a competitive edge. CBD isolate, recognized as the purest form of cannabidiol, contains no additional cannabinoids or plant compounds. In a notable development in September 2023, Apex Labs CBD, a US-based company offering a diverse range of high-quality CBD products, launched Pico IV, a CBD isolate specifically designed for intravenous (IV) therapy. Pico IV's sterile solution ensures safe intravenous use, catering to the increasing demand for CBD infusion in the rapidly expanding IV hydration therapy market. Distinguished by the reduction of the CBD molecule size to a picometer, Pico IV offers maximum absorption and is exclusively available for online purchase to licensed IV therapy providers.

In May 2022, Fresenius Kabi AG, a prominent healthcare company based in Germany, completed the acquisition of Ivenix Inc. The financial details of the transaction were undisclosed. This strategic move by Fresenius Kabi AG is aimed at establishing a comprehensive and innovative portfolio of top-tier infusion treatment solutions specifically tailored for the American market. Ivenix Inc., based in the United States, is recognized for pioneering a new generation of intravenous (IV) hydration therapy. The acquisition aligns with Fresenius Kabi AG's commitment to enhancing and diversifying its offerings in the healthcare sector, particularly in the realm of infusion treatments.

Major companies operating in the intravenous (IV) hydration therapy market include Revitalist, JW Life Science Corporation, NextGen Healthcare, Pfizer Inc., Fresenius Kabi AG, Liquid IV, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Elixir, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Harpal Clinic Ltd., Fosmo Med, Core IV Therapy LLC, Cryojuvenate UK Ltd., Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS, Vifor Pharma Management AG

North America was the largest region in the intravenous (IV) hydration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) hydration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the intravenous (iv) hydration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous (IV) Hydration Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous (iv) hydration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for intravenous (iv) hydration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous (iv) hydration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Intravenous (IV) Hydration Therapy Market Characteristics

3. Intravenous (IV) Hydration Therapy Market Trends And Strategies

4. Intravenous (IV) Hydration Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Intravenous (IV) Hydration Therapy Growth Analysis And Strategic Analysis Framework

6. Intravenous (IV) Hydration Therapy Market Segmentation

7. Intravenous (IV) Hydration Therapy Market Regional And Country Analysis

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market

9. China Intravenous (IV) Hydration Therapy Market

10. India Intravenous (IV) Hydration Therapy Market

11. Japan Intravenous (IV) Hydration Therapy Market

12. Australia Intravenous (IV) Hydration Therapy Market

13. Indonesia Intravenous (IV) Hydration Therapy Market

14. South Korea Intravenous (IV) Hydration Therapy Market

15. Western Europe Intravenous (IV) Hydration Therapy Market

16. UK Intravenous (IV) Hydration Therapy Market

17. Germany Intravenous (IV) Hydration Therapy Market

18. France Intravenous (IV) Hydration Therapy Market

19. Italy Intravenous (IV) Hydration Therapy Market

20. Spain Intravenous (IV) Hydration Therapy Market

21. Eastern Europe Intravenous (IV) Hydration Therapy Market

22. Russia Intravenous (IV) Hydration Therapy Market

23. North America Intravenous (IV) Hydration Therapy Market

24. USA Intravenous (IV) Hydration Therapy Market

25. Canada Intravenous (IV) Hydration Therapy Market

26. South America Intravenous (IV) Hydration Therapy Market

27. Brazil Intravenous (IV) Hydration Therapy Market

28. Middle East Intravenous (IV) Hydration Therapy Market

29. Africa Intravenous (IV) Hydration Therapy Market

30. Intravenous (IV) Hydration Therapy Market Competitive Landscape And Company Profiles

31. Intravenous (IV) Hydration Therapy Market Other Major And Innovative Companies

32. Global Intravenous (IV) Hydration Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous (IV) Hydration Therapy Market

34. Recent Developments In The Intravenous (IV) Hydration Therapy Market

35. Intravenous (IV) Hydration Therapy Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기